Clotrimazole and efaroxan stimulate insulin secretion by different mechanisms in rat pancreatic islets

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 356, Issue 6, 1997, Pages 763-768

  Chan, Susan L F ^a   Pallett, Anna L ^a   Morgan, Noel G ^a  

^a KEELE UNIVERSITY   (United Kingdom)

Author keywords

ATP sensitive K+ channel; Ca2+ activated K+ channel; Clotrimazole; Efaroxan; Insulin secretion; Islets of Langerhans

Indexed keywords

ADENOSINE TRIPHOSPHATE; CLOTRIMAZOLE; EFAROXAN; POTASSIUM CHANNEL;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; INSULIN RELEASE; NONHUMAN; PANCREAS ISLET; RAT;

EID: 0030732317     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00005116     Document Type: Article

References (26)

1. Boyd AE (1991) The role of ion channels in insulin secretion. J Cell Biochem 48: 234-241
2. + transport and cell dehydration in sickle erythrocytes by clotrimazole and other imidazole derivatives. J Clin Invest 92: 520-526
3. Brugnara C, Gee B, Armsby CC, Kurth S, Sakamoto M, Rifai N, Alper SL, Platt OS (1996) Therapy with oral clotrimazole induces inhibition of the Gardos channel and reduction of erythrocyte dehydration in patients with sickle cell disease. J Clin Invest 97: 1227-1234
4. 2-adrenoceptors and irnidazoline binding sites in control of insulin secretion. Clin Sci 85: 671-677
5. Chan SLF, Morgan NG (1990) Stimulation of insulin secretion by efaroxan may involve interaction with potassium channels. Eur J Pharmacol 176: 97-101
6. +-ATP channels in insulin secreting cells. Eur J Pharmacol 204: 41-48
7. 2-sites. Br J Pharmacol 112: 1065-1070
8. Chan SLF, Pallett AL, Clews, J, Ramsden CA, Morgan NG (1997) Evidence that the ability of imidazoline compounds to stimulate insulin secretion is not due to interaction with σ receptors. Eur J Pharmacol 323: 241-244
9. Coupry I, Armsby CC, Alper SL, Brugnara C, Parini A (1996) Clotrimazole and efaroxan inhibit red cell Gardos channel independently of imidazoline 11 and 12 binding sites. Eur J Pharmacol 295: 109-112
10. Dunne MJ (1991) Block of ATP-regulated potassium channels by phentolamine and other α-adrenoceptor antagonists. Br J Pharmacol 103: 1847-1850
11. Dunne MJ, Harding EA, Jaggar JH, Squires PE, Liang R, Kane C, James RFL, London NJ (1995) Potassium channels, imidazolines, and insulin-secreting cells. Ann N Y Acad Sci 763: 243-261
12. Fatherazi S, Cook DL (1991) Specificity of tetraethylammonium and quinine for 3 potassium channels in insulin secreting cells. J Memb Biol 120: 105-114
13. Gey GO, Gey MK (1936) Maintenance of human normal cells in continuous culture: preliminary report: cultivation of mesoblastic tumors and normal cells and notes on methods of cultivation. Am J Cancer 27: 45-76
14. + channels in the control of glucose-induced electrical activity in pancreatic B-cells. Pflügers Arch 416: 568-572
15. + channels in pancreatic β-cells. Br J Pharmacol 107: 8-14
16. 2+ in rat pancreatic islets. Proc Natl Acad Sci USA 92: 10728-10732
17. Michel MC, Ernsberger P (1992) Keeping an eye on the I-site: imidazoline-preferring receptors. Trends Pharmacol Sci 13: 369-370
18. Molderings GJ, Hentrich F, Gothert M (1991) Pharmacological characterization of the imidazoline receptor which mediates inhibtion of noradrenaline release in the rabbit pulmonary artery. Naunyn-Schmiedeberg's Arch Pharmacol 344: 630-638
19. Montague W, Taylor KW (1968) Pentitols and insulin release by isolated rat islets of Langerhans. Biochem J 109: 333-339
20. Morgan NG, Hurst RD, Berrow NS, Montague W (1988) Calcium handling by stimulated islets of Langerhans. Biochem Soc Trans 17: 64-66
21. 2 receptors. Eur J Pharmacol 262: 41-48
22. + channels in mouse pancreatic b-cells. Br J Pharmacol 101: 115-120
23. Plant TD, Jonas J-C, Henquin JC (1991) Clonidine inhibits ATP-sensitive potasssium channels in mouse pancreatic β-cells. Br J Pharmacol 104: 385-390
24. Regunathan S, Reis DJ (1996) Imidazoline receptors and their endogenous ligands. Annu Rev Pharmacol Toxicol 36: 511-544
25. Schulz A, Hasselblatt A (1989) An insulin-releasing property of imidazoline derivatives is not limited to compounds that block α-adrenoceptors. Naunyn-Schmiedeberg's Arch Pharmacol 340: 321-327
26. ATP channels and interaction with the exocytotic machinery. Diabetes 45: 1610-1618